FEMSA Reports Strong Q4 2025 Earnings, Completes €500M Bond Repayment, and Advances $260M Share Buyback

summarizeSummary

FEMSA reported strong Q4 2025 consolidated results, completed a €500M bond repayment, and is executing a $260M share buyback, alongside a strategic re-focus of its digital initiatives.

check_boxKey Events

• Strong Q4 2025 Consolidated Financial Performance

  FEMSA reported a 5.7% increase in total consolidated revenues and an 8.5% rise in income from operations for Q4 2025 compared to Q4 2024. Consolidated net income surged by 33.6%.

• Significant Capital Allocation Actions

  The company completed the final settlement and repayment of its €500 million exchangeable bonds. Additionally, FEMSA entered into a $260 million accelerated share repurchase agreement in December 2025, with final settlement expected in Q1 2026.

• Strategic Re-focus of Digital Ecosystem

  FEMSA is redefining its Ecosystem 2.0 to focus on OXXO Mexico, with Spin taking responsibility for the entire P&L and digital performance. This redefinition includes delaying the application for a banking license.

• Mixed Segment Performance

  Proximity Americas (OXXO) showed strong growth with revenues up 5.3% and income from operations up 7.7%. However, the Health division's income from operations decreased by 52.3% due to reclassification of expenses and a charge for uncollectible accounts. Coca-Cola FEMSA reported 2.9% revenue growth and 13.3% operating income growth, though normalized operating income growth was lower.

auto_awesomeAnalysis

FEMSA delivered robust consolidated financial results for the fourth quarter of 2025, with significant growth in total revenues, income from operations, and net income. The company also finalized the repayment of its €500 million exchangeable bonds, simplifying its capital structure, and continued its $260 million accelerated share repurchase program, demonstrating a commitment to shareholder returns. Strategically, FEMSA is re-focusing its digital Ecosystem 2.0 on OXXO Mexico, which includes delaying a banking license application, indicating a more concentrated approach to its digital financial services. While the Health division showed a significant decline in operating income and Coca-Cola FEMSA's normalized operating income growth was modest, the overall performance of core businesses and capital allocation initiatives are positive signals for investors.